RNU6-1232P

Across TCGA pan-cancer cohorts, RNU6-1232P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-1232P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-1232P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1232P expression acts as an unfavorable survival marker.

KIRC and SARC are the cancer types where RNU6-1232P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.136	0.724	<.001	132	view →
SARC	DFS	Tertile	All	0.095	0.632	.002	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RNU6-1232P–KIRC (OS)

Open the KIRC breakdown →